Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY: EW )

70.46 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Apr 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 953
Open 70.46
Bid (Size) 71.60 (3)
Ask (Size) 74.03 (1)
Prev. Close 70.46
Today's Range 70.46 - 70.46
52wk Range 58.93 - 95.25
Shares Outstanding 587,900,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Edwards Lifesciences Delivers In-Line Sales, Narrow Profit Beat
Edwards Lifesciences stock was flat late Wednesday after the medtech company beat profit views and delivered in-line sales. 
Via Investor's Business Daily
Topics ETFs
Edwards Lifesciences Reports First Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire

Performance

YTD
-2.93%
-2.93%
1 Month
-1.25%
-1.25%
3 Month
+2.06%
+2.06%
6 Month
-0.21%
-0.21%
1 Year
-19.70%
-19.70%

More News

Read More
A Look at Edwards Lifesciences's Upcoming Earnings Report
Via Benzinga
Eight-Year Data Confirm Long-Term Durability of Edwards’ RESILIA Tissue
From Edwards Lifesciences Corporation
Via Business Wire
Is Edwards Lifesciences Gaining or Losing Market Support?
Via Benzinga
A Look Into Edwards Lifesciences Inc's Price Over Earnings
Via Benzinga
Peering Into Edwards Lifesciences's Recent Short Interest
Via Benzinga
Stocks Surge On China Tariff Hopes, Tesla Jumps, Gold Loses Shine: What's Driving Markets Wednesday?
Via Benzinga
Topics Government
Exposures Political
Earnings Scheduled For April 23, 2025
Via Benzinga
Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025
From Edwards Lifesciences Corporation
Via Business Wire
Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
Via Benzinga
Trump Tariffs Spare Drugmakers But Threaten Diabetes Device Industry
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients
From Edwards Lifesciences Corporation
Via Business Wire
Jim Cramer: Healthpeak Properties Is A 'Reasonable' REIT, Recommends Buying This Health Care Stock
Via Benzinga
How Is The Market Feeling About Edwards Lifesciences?
Via Benzinga
Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference
From Edwards Lifesciences Corporation
Via Business Wire
Top S&P500 movers in Wednesday's session
Via Chartmill
Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength
Via Benzinga
These S&P500 stocks are moving in today's session
Via Chartmill
Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?
Via Benzinga
Topics Economy
Exposures Interest Rates
Discover the top S&P500 movers in Wednesday's pre-market session.
Via Chartmill
Edwards Beats Fourth-Quarter Forecasts, But Shares Slip
Via Investor's Business Daily
Edwards Lifesciences Reports Fourth Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
US Stocks Dip As Powell Stays Cautious, Intel Climbs, Tesla Sinks To 11-Week Low: What's Driving Markets Tuesday?
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.